Janux Therapeutics, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 2,450.97%-898.32%-732.22%-721.18%-651.62%
EBIT Margin 2,350.97%-905.39%-779.04%-902.87%-933.58%
EBITDA Margin 3,293.20%-905.75%-746.91%-693.96%-637.48%
Operating Margin 2,350.97%-905.39%-779.04%-902.87%-933.58%
Net Margin 2,450.97%-898.32%-732.22%-721.18%-651.62%
FCF Margin 2,192.23%-507.51%-573.24%-648.58%-417.20%
Efficiency
Assets Average 198.02M371.92M372.21M720.96M
Equity Average 175.84M343.53M332.54M683.57M
Invested Capital -14.64M366.33M320.74M344.35M1,022.78M
Asset Utilization Ratio 0.020.020.020.01
Leverage & Solvency
Interest Coverage Ratio -23.51
Equity Ratio -0.900.960.880.910.96
Times Interest Earned -23.51
Valuation
Enterprise Value -7.81M446.03M221.69M151.36M1,784.71M
Market Capitalization 821.00M548.70M495.39M2,809.89M
Return Ratios
Return on Sales 24.51%-8.98%-7.32%-7.21%-6.52%
Return on Capital Employed -0.18%-0.19%-0.20%-0.14%
Return on Assets -0.16%-0.17%-0.16%-0.10%
Return on Equity -0.19%-0.18%-0.18%-0.10%